Skip to main navigation Skip to search Skip to main content

Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update

  • Andreea Ciudin*
  • , Jennifer L. Baker
  • , Andrej Belancic
  • , Luca Busetto
  • , Dror Dicker
  • , Lubomira Fabryova
  • , Gema Fruhbeck
  • , Gijs H. Goossens
  • , Jason Gordon
  • , Matteo Monami
  • , Paolo Sbraccia
  • , Borja Martinez-Tellez
  • , Volkan Yumuk
  • , Barbara McGowan*
  • *Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Abstract

This 2026 update integrates emerging trial evidence — particularly for weight loss and liver disease — to refine EASO’s treatment algorithm for obesity management.

Original languageEnglish
Pages (from-to)1962-1966
Number of pages5
JournalNature Medicine
Volume32
Issue number6
Early online date1 May 2026
DOIs
Publication statusPublished - Jun 2026

Fingerprint

Dive into the research topics of 'Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update'. Together they form a unique fingerprint.

Cite this